Table 2. Factors associated with not using EMM^ within first month of diagnosis among eligible notified people with TB in the 30 selected counties of China between July and December, 2018^^.
Factors | Total | Not using EMM^ | PR | (95% CI) | aPR@ | (95% CI) | ||
---|---|---|---|---|---|---|---|---|
n | (%) | |||||||
Total | 1810 | 763 | (42.2) | - | - | - | - | |
Age in years | ||||||||
<15 | 8 | 5 | (62.5) | 1.6 | (0.90–2.69) | 1.9 | (1.01–3.39)* | |
15–44 | 629 | 252 | (40.1) | ref | ref | |||
45–64 | 667 | 274 | (41.1) | 1.0 | (0.90–1.17) | 1.1 | (0.91–1.19) | |
> = 65 | 506 | 232 | (45.9) | 1.1 | (1.00–1.31)* | 1.3 | (1.13–1.54)* | |
Sex | ||||||||
Male | 1221 | 505 | (41.4) | ref | ref | |||
Female | 589 | 258 | (43.8) | 1.1 | (0.95–1.19) | 1.1 | (0.95–1.19) | |
Occupation | ||||||||
Farmers and herdsmen | 816 | 309 | (37.9) | ref | ref | |||
Semi-skilled employee | 168 | 71 | (42.3) | 1.1 | (0.92–1.36) | 1.2 | (1.01–1.52)* | |
Salary employee | 194 | 93 | (47.9) | 1.3 | (1.07–1.50)* | 1.1 | (0.97–1.37) | |
Unemployed | 450 | 217 | (48.2) | 1.3 | (1.12–1.45)* | 1.2 | (1.02–1.35)* | |
Studying | 100 | 38 | (38.0) | 1.0 | (0.77–1.31) | 0.9 | (0.70–1.27) | |
Others | 82 | 35 | (42.7) | 1.1 | (0.86–1.47) | 1.2 | (0.91–1.57) | |
Migrant** | ||||||||
No | 1733 | 736 | (42.5) | 1.2 | (0.89–1.65) | 1.2 | (0.86–1.61) | |
Yes | 77 | 27 | (35.1) | ref | ref | |||
Classification | ||||||||
Bacteriologically confirmed PTB | 980 | 396 | (40.4) | ref | ref | |||
Clinically diagnosed PTB | 672 | 278 | (41.4) | 1.0 | (0.91–1.15) | 1.1 | (0.97–1.23) | |
Pleurisy | 158 | 89 | (56.3) | 1.4 | (1.19–1.63)* | 1.6 | (1.34–1.83)* | |
Category | ||||||||
New | 1716 | 708 | (41.3) | ref | ref | |||
Previously treated | 94 | 55 | (58.5) | 1.4 | (1.19–1.70)* | 1.6 | (1.32–1.88)* | |
Treatment initiation interval (days)# | ||||||||
Zero | 1731 | 729 | (42.1) | ref | ref | |||
≥ One | 79 | 34 | (43.0) | 1.0 | (0.79–1.32) | 1.2 | (0.89–1.52) |
Row percentages
TB–tuberculosis; PTB–pulmonary TB;EMM- Electronic Medication Monitor; PR–prevalence ratio; aPR–adjusted prevalence ratio; CI–confidence interval
^ Includes those who used EMM later during treatment or never used EMM during treatment
^^ Of 2294 notified people with TB, 2227 has EMM eligibility data recorded. Of 2227, 1810 were eligible to use EMM at notification. Of 1810, 1047 used EMM within first month of diagnosis.
@ Adjusted prevalence ratios (95% CI) calculated using log binomial regression. We included all the variables including county in the multivariable analysis (county not shown in the table)
* Statistically significant
** Migrant defined as patients staying in the same prefecture for less than six months
# Time interval from diagnosis to treatment, the median interval was zero days and used as cut-off to categorize